Copy
If this email does not display correctly, click here
Newsletter #135
September 13th, 2018
YouTube LinkedIn Google+ Twitter
Editorial

Dear Friends,

We begin this newsletter with an infographic created by the International Scientific Association for Probiotics and Prebiotics (ISAPP), which addresses some of the more common fallacies regarding probiotics.

 

Next comes an article about the new World Gastroenterology Organization (WGO) Guidelines on Diet & The Gut, which aims to provide up-to-date practice recommendations to medical practitioners around the world. We also cover a systematic review that reveals how probiotics are associated with a lower risk of symptomatic C. difficile infection, and without showing an increase in adverse events in children and adults who have been prescribed antibiotics. You then have a brief report written by Mary Ellen Sanders on the main highlights from ISAPP’s annual meeting, which was held for the first time in Asia, on June 5-7. We continue with a study that explores novel fecal microbiota associations with common diseases and medications revealed in a TwinsUK cohort. Finally, we discuss an article showing that the probiotic L. rhamnosus CNCM I-3690 counteracts pathobiont-driven metabolic effects and gut barrier dysfunction in mice.

The GMFH publishing team

ISAPP dispels myths about probiotics in new infographic
GMFH
New practice guidelines to help medical practitioners consider the gut microbiota

New practice guidelines to help medical practitioners consider the gut microbiota


Patients with gastrointestinal diseases often experience symptoms (diarrhea, constipation, abdominal pain, bloating) that worsen after...


Share: Facebook Twitter Google+ Linkedin Email  
A recent Cochrane review shows that probiotics appear to be effective and safe in preventing Clostridium difficile infection

A recent Cochrane review shows that probiotics appear to be effective and safe in preventing Clostridium difficile infection


The administration of broad-spectrum antibiotics is an important risk factor for Clostridium difficile infection (CDI) in...


Share: Facebook Twitter Google+ Linkedin Email  
Highlights from the ISAPP 2018 Meeting in Singapore

Highlights from the ISAPP 2018 Meeting in Singapore


On June 5-7, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened its...


Share: Facebook Twitter Google+ Linkedin Email  
Novel fecal microbiota associations with common diseases and medications revealed in the TwinsUK cohort

Novel fecal microbiota associations with common diseases and medications revealed in the TwinsUK cohort


While changes in the human gut microbiome’s composition and function have been related to several diseases and types of...


Share: Facebook Twitter Google+ Linkedin Email  
The probiotic L. rhamnosus CNCM I-3690 counteracts pathobiont-driven metabolic effects and gut barrier dysfunction in mice

The probiotic L. rhamnosus CNCM I-3690 counteracts pathobiont-driven metabolic effects and gut barrier dysfunction in mice


The prevalence of obesity and related metabolic conditions is increasing worldwide and has become a major...


Share: Facebook Twitter Google+ Linkedin Email  
©2018 Gut Microbiota For Health
If you need further information send us an email to contact@gutmicrobiotaforhealth.com

You have received this e-mail because you have shown an interest in receiving news from us. If you don’t want to continue receiving information from us, please unsubscribe

www.gutmicrobiotaforhealth.com is edited by
ESNM
 
Unsubscribe from this list Update subscription preferences
Before print this message, please check that it is really necessary